SPRITZE

European patent · EP2869813 · Deleted

Register entry

Publication number
EP2869813
Application number
EP13701276
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jan 25, 2013
Published
May 13, 2015
Granted
Nov 21, 2018
Deleted
Aug 3, 2022
Reason
Revoked in opposition
IPC classes
A61K 9/00 (2006.01)
A61M 5/28 (2006.01)
A61M 5/31 (2006.01)
A61M 5/315 (2006.01)
Priority
EP 12174860 03.07.2012
EP 12189649 23.10.2012
DE 202012011016 U 16.11.2012
AU 2012101677 16.11.2012
AU 2012101678 16.11.2012
DE 202012011260 U 23.11.2012
DE 202012011259 U 23.11.2012
EP 12195360 03.12.2012
DE 202013000688 U 23.01.2013
AU 2013100071 23.01.2013
AU 2013100070 23.01.2013
PCT application
PCT/EP2013/051491 25.01.2013
PCT publication
WO2014/005728 09.01.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 3, 2022

    Change

    Published in Swissreg on 03.08.2022

  2. Sep 22, 2021

    Change

    Published in Swissreg on 22.09.2021

  3. Sep 22, 2021

    Change

    Published in Swissreg on 22.09.2021

  4. Nov 21, 2018

    Granted

    Published in Swissreg on 21.11.2018

Parties

Holder

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventor

ROYER, Christophe

CH-4002 Basel

PICCI, Marie

CH-4002 Basel

BRYANT, Andrew Mark

CH-4002 Basel

SIGG, Juergen

CH-4002 Basel

BUETTGEN, Heinrich Martin

CH-4002 Basel

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.